Cargando…
Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor
Caffeine has been reported to induce anti-tumor immunity for attenuating breast cancer by blocking the adenosine 2A receptor. Molecular modeling showed that theacrine, a purine alkaloid structurally similar to caffeine, might be an antagonist of the adenosine 2A receptor equivalent to or more effect...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706909/ https://www.ncbi.nlm.nih.gov/pubmed/34946538 http://dx.doi.org/10.3390/molecules26247455 |
_version_ | 1784622307076997120 |
---|---|
author | Jhuo, Cian-Fen Hsu, Yu-Yu Chen, Wen-Ying Tzen, Jason T. C. |
author_facet | Jhuo, Cian-Fen Hsu, Yu-Yu Chen, Wen-Ying Tzen, Jason T. C. |
author_sort | Jhuo, Cian-Fen |
collection | PubMed |
description | Caffeine has been reported to induce anti-tumor immunity for attenuating breast cancer by blocking the adenosine 2A receptor. Molecular modeling showed that theacrine, a purine alkaloid structurally similar to caffeine, might be an antagonist of the adenosine 2A receptor equivalent to or more effective than caffeine. Theacrine was further demonstrated to be an effective antagonist of the adenosine 2A receptor as its concurrent supplementation significantly reduced the elevation of AMPK phosphorylation level in MCF-7 human breast cells induced by CGS21680, an agonist of adenosine 2A receptors. In an animal model, the development of mammary carcinoma induced by 7,12-Dimethylbenz[a]anthracene in Sprague–Dawley rats could be attenuated by daily supplement of theacrine of 50 or 100 mg/kg body weight. Both expression levels of cleaved-caspase-3/pro-caspase-3 and granzyme B in tumor tissues were significantly elevated when theacrine was supplemented, indicating the induction of programmed cell death in tumor cells might be involved in the attenuation of mammary carcinoma. Similar to the caffeine, significant elevation of interferon-γ and tumor necrosis factor-α was observed in the serum and tumor tissues of rats after the theacrine supplement of 50 mg/kg body weight. Taken together, theacrine is an effective antagonist of adenosine 2A receptors and possesses great potential to be used to attenuate breast cancer. |
format | Online Article Text |
id | pubmed-8706909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87069092021-12-25 Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor Jhuo, Cian-Fen Hsu, Yu-Yu Chen, Wen-Ying Tzen, Jason T. C. Molecules Article Caffeine has been reported to induce anti-tumor immunity for attenuating breast cancer by blocking the adenosine 2A receptor. Molecular modeling showed that theacrine, a purine alkaloid structurally similar to caffeine, might be an antagonist of the adenosine 2A receptor equivalent to or more effective than caffeine. Theacrine was further demonstrated to be an effective antagonist of the adenosine 2A receptor as its concurrent supplementation significantly reduced the elevation of AMPK phosphorylation level in MCF-7 human breast cells induced by CGS21680, an agonist of adenosine 2A receptors. In an animal model, the development of mammary carcinoma induced by 7,12-Dimethylbenz[a]anthracene in Sprague–Dawley rats could be attenuated by daily supplement of theacrine of 50 or 100 mg/kg body weight. Both expression levels of cleaved-caspase-3/pro-caspase-3 and granzyme B in tumor tissues were significantly elevated when theacrine was supplemented, indicating the induction of programmed cell death in tumor cells might be involved in the attenuation of mammary carcinoma. Similar to the caffeine, significant elevation of interferon-γ and tumor necrosis factor-α was observed in the serum and tumor tissues of rats after the theacrine supplement of 50 mg/kg body weight. Taken together, theacrine is an effective antagonist of adenosine 2A receptors and possesses great potential to be used to attenuate breast cancer. MDPI 2021-12-09 /pmc/articles/PMC8706909/ /pubmed/34946538 http://dx.doi.org/10.3390/molecules26247455 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jhuo, Cian-Fen Hsu, Yu-Yu Chen, Wen-Ying Tzen, Jason T. C. Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title | Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title_full | Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title_fullStr | Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title_full_unstemmed | Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title_short | Attenuation of Tumor Development in Mammary Carcinoma Rats by Theacrine, an Antagonist of Adenosine 2A Receptor |
title_sort | attenuation of tumor development in mammary carcinoma rats by theacrine, an antagonist of adenosine 2a receptor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706909/ https://www.ncbi.nlm.nih.gov/pubmed/34946538 http://dx.doi.org/10.3390/molecules26247455 |
work_keys_str_mv | AT jhuocianfen attenuationoftumordevelopmentinmammarycarcinomaratsbytheacrineanantagonistofadenosine2areceptor AT hsuyuyu attenuationoftumordevelopmentinmammarycarcinomaratsbytheacrineanantagonistofadenosine2areceptor AT chenwenying attenuationoftumordevelopmentinmammarycarcinomaratsbytheacrineanantagonistofadenosine2areceptor AT tzenjasontc attenuationoftumordevelopmentinmammarycarcinomaratsbytheacrineanantagonistofadenosine2areceptor |